Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 3/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26912007 | 0.88 | USP2 (0.41) | USP2SMN1; SMN2GPR119 | |
| SCHEMBL20228010 | 0.81 | USP2 (0.45) | USP2SMN1; SMN2CYP11B2USP30SCD5 | |
| SCHEMBL29130003 | 0.78 | GPR119 (0.45) | USP2SMN1; SMN2RORCGPR119 | |
| SCHEMBL2218857 | 0.78 | USP2 (0.41) | USP2SMN1; SMN2RORCCYP11B2USP30 | |
| SCHEMBL31543328 | 0.78 | USP2 (0.41) | USP2SMN1; SMN2CYP11B2USP30SCD5 | |
| SCHEMBL4210880 | 0.77 | USP2 (0.50) | USP2SMN1; SMN2RORCCYP11B2USP30 | |
| SCHEMBL28896482 | 0.75 | CYP4F2 (0.40) | USP2SMN1; SMN2RORCGPR119CYP11B2 | |
| SCHEMBL28896586 | 0.75 | USP2 (0.40) | USP2SMN1; SMN2CYP11B2USP30SCD5 | |
| SCHEMBL15770893 | 0.75 | USP2 (0.49) | USP2SMN1; SMN2GPR119 | |
| SCHEMBL21358469 | 0.75 | CYP2C19 (0.46) | USP2SMN1; SMN2GPR119CYP11B2SCD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239794-A1 | PKC-Theta Modulators | EXSCIENTIA AI LIMITED (GB) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239794-A1 | PKC-Theta Modulators | PRKCQ, PRKCH, PRKCZ | USP2 4177/4885SMN1; SMN2 1674/4885RORC 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.